← Back to S&P 500 Dashboard

CNC

INSUFFICIENT DATA

Centene Corporation

Healthcare · Rank #497 · Analyzed Apr 20, 2026

$38.17

Current Price

$32.63

Intrinsic Value

-14.5%

Upside/Downside

0/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus0/1 methods agree
Quality Score1/5.0
Framework RatingINSUFFICIENT DATA
Price vs Intrinsic ValueOvervalued by 14.5%

Fair Value Range

Low$32.63
Base (IV)$32.63
High$32.63

Entry Points

Conservative$32.63
Moderate$32.63
Aggressive$32.63

⚠️ Warnings

  • DCF discarded: negative profit margins
  • Unusually high FCF yield (20%) — DCF may be unreliable
  • Insufficient data: fewer than 2 valuation methods

Quality & Moat Breakdown

Return on Equity-28.7% → 0/1.0
Debt LevelD/E 91 → 0/1.0
Revenue QualityGrowth 23.7%, margin Δ-3.8% +recovery → 1.0/1.0
Moat Strength2.0/5 → 0/1.0
Profit Margins-3.8% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.